- Home
- ELVN vs SLG Comparison
ELVN vs SLG Comparison
Compare ELVN & SLG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ELVN | SLG |
|---|---|---|
| Founded | 2016 | 1980 |
| Country | United States | United States |
| Employees | N/A | 1289 |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 2.6B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | ELVN | SLG |
|---|---|---|
| Price | $41.49 | $42.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 19 |
| Target Price | $43.40 | ★ $50.63 |
| AVG Volume (30 Days) | 925.8K | ★ 1.2M |
| Earning Date | 05-11-2026 | 04-15-2026 |
| Dividend Yield | N/A | ★ 7.29% |
| EPS Growth | ★ 3.17 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $14.79 | $34.77 |
| 52 Week High | $48.53 | $66.91 |
Technical Indicators
Market Signals| Indicator | ELVN | SLG |
|---|---|---|
| Relative Strength Index (RSI) | 50.84 | 55.16 |
| Support Level | $16.84 | $35.66 |
| Resistance Level | $48.53 | $44.71 |
| Average True Range (ATR) | 2.29 | 1.70 |
| MACD | -0.97 | -0.02 |
| Stochastic Oscillator | 17.12 | 47.85 |
Price Performance
Historical ComparisonAbout ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. The product candidates of the company include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About SLG SL Green Realty Corp
SL Green Realty is one of the largest Manhattan property owners and landlords, with interest in around 32 million square feet of wholly owned and joint-venture office space. The company has additional property exposure through its limited portfolio of well-located retail space. It operates as a real estate investment trust.